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Chk1 both arrests replication forks and enhances repair of
DNA damage by phosphorylating downstream effectors.
Although there has been a concerted effort to identify
effectors of Chk1 activity, underlying mechanisms of
effector action are still being identiﬁed. Metnase (also
called SETMAR) is a SET and transposase domain
protein that promotes both DNA double-strand break
(DSB) repair and restart of stalled replication forks. In
this study, we show that Metnase is phosphorylated only
on Ser495 (S495) in vivo in response to DNA damage by
ionizing radiation. Chk1 is the major mediator of this
phosphorylation event. We had previously shown that
wild-type (wt) Metnase associates with chromatin near
DSBs and methylates histone H3 Lys36. Here we show
that a Ser495Ala (S495A) Metnase mutant, which is not
phosphorylated by Chk1, is defective in DSB-induced
chromatin association. The S495A mutant also fails to
enhance repair of an induced DSB when compared with wt
Metnase. Interestingly, the S495A mutant demonstrated
increased restart of stalled replication forks compared
with wt Metnase. Thus, phosphorylation of Metnase S495
differentiates between these two functions, enhancing
DSB repair and repressing replication fork restart. In
summary, these data lend insight into the mechanism by
which Chk1 enhances repair of DNA damage while at the
same time repressing stalled replication fork restart.
Oncogene (2012) 31, 4245–4254; doi:10.1038/onc.2011.586;
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Introduction
Metnase, also known as SETMAR, is a SET (Su(var)3-
9, Enhancer-of-zeste, Trithorax) and a transposase
fusion protein present only in anthropoid primates
(Robertson and Zumpano, 1997; Lee et al., 2005;
Cordaux et al., 2006; Jordan, 2006). The Metnase SET
domain dimethylates histone H3 lysine 36 (H3K36me2;
Lee et al., 2005), while the transposase domain has most
but not all of the classic transposase nuclease activities,
including 50-terminal inverted repeats-speciﬁc DNA
binding, DNA looping, assembly of paired-end complex
and DNA cleavage (Liu et al., 2007).
We found that Metnase enhances non-homologous
end joining and promotes genomic integration of foreign
DNA, perhaps via its association with DNA Ligase IV
(Lee et al., 2005, Hromas et al., 2008). Both the histone
methylase and nuclease domains are essential for
Metnase-mediated double-strand break (DSB) repair
and genomic integration in vivo (Lee et al., 2005). The
SET domain is responsible for dimethylating H3K36
adjacent to induced DNA DSBs, and this dimethylation
stabilizes the Ku and MRN complex at the DSB, which
explains Metnase enhancement of DSB repair (Fnu
et al., 2011). Metnase is also important for timely restart
of stalled replication forks, perhaps by decatenating
positively supercoiled DNA in front of the fork (Roman
et al., 2007; Williamson, et al., 2008; Wray et al., 2009;
De Haro et al., 2010). Interestingly, although Metnase is
only present in primates (Lee et al., 2005; Cordaux et al.,
2006), it functions with the murine NHEJ repair
apparatus when overexpressed in these non-primate
cells, and enhances DNA repair in that organism as well
(Wray et al., 2010).
Replication fork arrest upon DNA damage is
regulated by a cascade of phosphorylation events,
initiated upon damage sensing by ATM/ATR, with
effectors of fork arrest and DNA repair as targets (Zhou
and Elledge, 2000). As Metnase is a novel component of
the DSB repair pathway, we hypothesized that it was
also regulated by phosphorylation. Therefore, in this
study, we explored the phosphorylation of Metnase
upon DNA damage and the origin and consequences of
that phosphorylation. We discovered that Metnase is
Received 23 May 2011; revised 18 October 2011; accepted 9 November
2011; published online 9 January 2012
Correspondence: Dr R Hromas, Department of Medicine, University
of Florida and Shands Health Care System, 1600 SW Archer Rd,
Gainesville, FL 32610, USA.
E-mail: robert.hromas@medicine.uﬂ.edu or Professor S-H Lee De-
partment of Biochemistry/Molecular Biology and Medicine, Indiana
University Cancer Center, Indiana University Medical Center, Indianapo-
lis, IN, USA.
E-mail: slee@ipui.edu
5These authors contributed equally to this work.
Oncogene (2012) 31, 4245–4254
& 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12
www.nature.com/onc
phosphorylated on Ser495 (S495) in response to DNA
damage, mainly by Chk1, and dephosphorylated by
PP2A. A Ser495Ala (S495A) mutant of Metnase was not
phosphorylated by Chk1, and had decreased localiza-
tion to induced DSBs. This decreased DSB association
resulted in decreased H3K36me2 formation near the
DSB. In addition, the S495A mutant demonstrated
decreased religation capacity of an induced DSB.
Interestingly, the S495A mutant had an increased ability
to restart stalled replication forks. Thus, Chk1 phos-
phorylation differentiates between the ability of Met-
nase to repair DSBs and its ability to enhance
replication fork recovery. These data reveal an epistatic
link between Chk1 damage sensing and DSB repair
through stimulation of the DSB repair function of
Metnase. They also shed light on the mechanism by
which Chk1 mediates two of its major functions, cell
cycle (replication) arrest and DNA repair.
Results
Metnase is phosphorylated on S495 in response to DNA
damage
Because protein phosphorylation has key roles in
regulating DNA replication and repair, we investigated
whether Metnase, which has roles in both of these
processes, is also phosphorylated. Metnase possesses
several sites that could potentially be phosphorylated by
kinases known to be active in DNA replication and
repair. There are two ATM/ATR consensus sites, 50-
DIDPTQ-56 and 639-FVESQ-643 (Kim et al., 1999).
In addition, the sequence surrounding S495 (489-
YDNRRRSA-496) overlaps a Chk1/2 consensus target
phosphorylation site (LxRxxS) with a p21-activated
kinase (PAK) consensus site (Brzeska et al., 1997;
O’Neill et al., 2002), and it is also a possible site for
protein kinase C (PKC). Each of these kinases can be
activated by DNA damage, and are candidates for
phosphorylation of Metnase (Canman et al., 1998;
Matsuoka et al., 1998; Roig and Traugh, 1999). We
ﬁrst tested whether Metnase is phosphorylated in vivo
after DNA damage. Inorganic 32P was indeed incorpo-
rated into Metnase in vivo, and this incorporation was
markedly enhanced following DNA damage with
ionizing radiation (IR) (Figure 1a). Incorporation of
32P into Metnase was due to protein phosphorylation,
because most of the incorporated 32P was removed
following incubation with l-protein phosphatase
(Figure 1a). There is a baseline level of Metnase
phosphorylation observed in the absence of IR treat-
ment (Figure 1a, lane 1), which may be due to
phosphorylation of Metnase in response to endogenous
DNA damage during cell cycle progression (Kastan,
2001; Wilkes et al., 2003).
To further dissect Metnase phosphorylation, we
carried out two-dimensional phosphopeptide mapping
analysis of Metnase after IR. Human embryonic kidney
293 (HEK-293) cells overexpressing Flag-Metnase were
metabolically labeled with 32P-orthophosphate, Metnase
was immunoprecipitated using anti-Flag, and the
immunoprecipitate was analyzed by 2D gel electrophor-
esis for peptide(s) carrying 32P. A single phosphopeptide
was identiﬁed, and whose presence was found to be
signiﬁcantly enhanced following IR (Figure 1b). To
determine phosphorylation site of Metnase in vivo,
Metnase was immunoprecipitated from HEK-293 cells
overexpressing Flag-Metnase following IR (20Gy), and
analyzed for phosphopeptide(s) using nano-LC/MS/
MS. This analysis showed only one phosphopeptide,
which perfectly matched the S495 domain (Figure 1b,
Supplementary Figure 1). To examine whether S495 was
the only Metnase phosphorylation site, we generated a
S495A mutant of Metnase, and expressed it in HEK-293
cells. The S495A Metnase species showed no phosphor-
ylation in vivo when cells were incubated with 32P and
irradiated (Figure 1c). This result was consistent with
the 2D gel mapping result, which identiﬁed a single
phosphopeptide following IR treatment.
Phosphorylation of Metnase S495 by Chk1
S495 occurs within a Chk1, Chk2 and PAK consensus
phosphorylation sequence (RxxS), as mentioned above.
This site is in the DDE-like transposase nuclease
domain, although not in the active site (Figure 2a,
Supplementary Figure 2). We virtually modeled the
three-dimensional location of the S495 site within the
Metnase tertiary structure (Supplementary Figure 2).
Our previous structural analysis indicated that the
Metnase DNA-binding site positioned the DNA strand
across the groove where S495 is located, as the DNA
approaches the catalytic triad at the active site (Good-
win et al., 2010, Supplementary Figure 2). Our model
indicates that the region is quite ﬂexible, but that
phosphorylation could affect the mobility of this region.
This in turn may inﬂuence DNA positioning relative to
the catalytic triad. Thus, this model suggests that the
nuclease function of Metnase could be altered by
phosphorylation (see below).
Figure 1 IR-induced phosphorylation of Metnase. (a) Cells
overexpressing Flag-Metnase were incubated with 32P-orthopho-
sphoric acid for 1 h and then exposed to 20Gy IR. Metnase was
immunoprecipitated using anti-Flag, electrophoretically separated
and autoradiographed. The loss of signal after l-phosphatase
implies a direct phosphorylation event. (b) Two-dimensional
phosphopeptide mapping analysis of 32P-Metnase following IR
treatment demonstrated only one species, and this species was
induced following IR. This phosphopeptide was isolated and
analyzed for amino-acid sequence (Supplementary Figure 1). The
phosphorylation occurred at S495. (c) Phosphorylation analysis of
Metnase and the S495A mutant in vivo after 20Gy IR. The wt
and S495A mutant of Metnase were immunoprecipitated after
32P-labeling. Only the wt Metnase was phosphophorylated, shown
in magniﬁed form in the right panel.
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We examined whether Chk1, Chk2 or PAK2 could
phosphorylate the S495 of Metnase using in vitro kinase
assays. Pure recombinant Chk1, Chk2 and PAK2 were
incubated with pure recombinant Metnase nuclease
fragment (Roman et al., 2007) and 32P-ATP. Proteins
were segregated by denaturing gel electrophoresis, and
phosphorylated species were detected by autoradiogra-
phy. Although both Chk2 and PAK2 phosphorylated
Metnase to some extent, Chk1 had at least 8-fold greater
activity for Metnase than Chk2 and PAK2 (Figure 2b).
We then generated an antibody against phosphorylated
S495 of Metnase (anti-pS495), and tested whether it
could recognize phosphorylated Metnase (Figure 2c).
V5-tagged Metnase was immunoprecipitated and trea-
ted with l-phosphatase or untreated. Anti-pS495
recognized only the untreated, phosphorylated form of
Metnase (Figure 2c). We then examined the ability of
several kinase inhibitors to block the phosphorylation of
Metnase (Figure 2d). As cell populations have a fraction
of phosphorylated Metnase present constitutively, as
noted above, we analyzed the effect of kinase inhibitors
without inducing DNA damage. The Chk1 inhibitor
UCN-01 signiﬁcantly decreased the presence of phos-
phorylated Metnase. The pan-kinase inhibitor stauros-
porine was partially inhibitory, but the other kinase
inhibitors, including the PKC inhibitor G109203X, had
little or no effect.
As PP2A has been reported to antagonize the effects
of Chk1 (Leung-Pineda et al., 2006), we tested whether
the PP1/PP2A inhibitor okadaic acid could reverse the
dephosphorylation of Metnase (Figure 2e). We found
that okadaic acid did indeed increase the phosphoryla-
tion of Metnase, and overcame the decrease in
phosphorylation seen with UCN-01. However, okadaic
acid worked only when it was added prior to UCN-01,
indicating that there is dynamic phosphorylation and
dephosphorylation of Metnase within the cell.
Becasue kinase inhibitors can have off-target effects,
it was possible that the decrease in S495 phosphoryla-
tion seen with UCN-01 could have been due to its minor
activity against Chk2. Therefore, we used previously
characterized short hairpin RNA to repress the expres-
sion of Chk1, and examined whether this altered the
level of pS495. We found that even mildly decreasing
Chk1 expression nearly completely abrogated Metnase
phosphorylation (Figure 3a). In like manner, okadaic
acid inhibits both PP1 and PP2A. We used short hairpin
RNA to repress PP2A speciﬁcally, and found that it
signiﬁcantly increased the Metnase phosphorylation
(Figure 3b), indicating that PP2A speciﬁcally depho-
sphorylates Metnase. When PP2A was repressed,
the activity of Chk1 was unopposed and Metnase
phosphorylation increased.
Metnase phosphorylation regulates replication fork
recovery and DNA repair
Metnase enhances DNA DSB repair via its histone
methylase activity (Fnu et al., 2011). After a DNA DSB
is formed, Metnase associates with chromatin adjacent
to the DSB and dimethylates H3K36. This dimethyla-
tion stabilizes NHEJ components, such as the Ku
complex, at the DSB and increases the religation of
the DSB (Fnu et al., 2011). We isolated chromatin
before and after IR and hydroxyurea (HU) to measure
its association with wild-type (wt) and S495A mutant
Metnase by western blot analysis (Figure 4a). We found
that IR-induced DNA damage modestly increased the
amount of total Metnase associated with chromatin
Figure 2 Phosphorylation of Metnase by Chk1 in vitro.
(a) Schematic diagram of Metnase. The PreSET domain contains
a cysteine- and histidine-rich putative Zn2þ -binding motif, and the
SET domain has the histone methylase motif. The transposase
nuclease domain contains the two conserved motifs, HTH and
DDE-like (in Metnase this is DDN; Roman et al., 2007). S495 is
within RxxS Chk1/2/Pak consensus sites. (b) Chk1 phosphorylates
Metnase in vitro much more efﬁciently than Chk2 and PAK2.
In vitro phosphorylation of pure recombinant Metnase by pure
recombinant Chk1, Chk2 and PAK2 kinases, with and without
their inhibitors (UCN-01, CKII and staurosporin, respectively), is
shown. (c) The anti-phospho-Ser495 (anti-pS495) antibody recog-
nizes phosphorylated Metnase. V5-tagged wt Metnase was
immunoprecipitated from HEK-293T cells using the V5 tag, and
treated with 400U l-protein phosphatase in the presence or absence
of phosphatase inhibitors (as described in Materials and methods).
The immunoprecipitate was analyzed for the presence of phos-
phorylated S495 using speciﬁc anti-sera. The loss of signal upon
phosphatase treatment implies the direct phosphorylation of
Metnase at S495. (d) Metnase phosphorylation in vivo in the
presence of kinase inhibitors, listed above the panel. Below the
panel are the types of kinases inhibited. The Chk1 inhibitor, and to
a lesser extent the pan-kinase inhibitor, block the phosphorylation
of S495 on Metnase as detected by western blot analysis using anti-
pSer495 after immunoprecipitation of V5-tagged wt Metnase. The
samples are as follows: (1) no treatment; (2) UCN-01 (Chk1
inhibitor); (3) CKII (Chk2 inhibitor); staurosporine (pan-kinase
inhibitor, including PAK2 and Chk1); PD90859 (ERK2 inhibitor);
and GF109203X (PKC inhibitor). (e) The PP2A inhibitor okadaic
acid reverses the ability of the Chk1 kinase inhibitor UCN-01 to
inhibit phosphorylation of Metnase S495. After immunoprecipita-
tion of V5-tagged wt Metnase from cells pretreated with UCN-01,
okadaic acid or both, pS495 was detected using western blot
analysis. Okadaic acid was effective only when it was added prior
to UCN-01.
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(1.3-fold) 1 h after IR. However, the S495A Metnase
had little constitutive association with chromatin and no
increase after IR (Figure 4a). It should be noted that the
S495A species was expressed at lower levels than wt
Metnase (Figure 4a, right panel), but not to the same
extent as the decrease in the association of the S495A
with chromatin. Interestingly, phosphorylated Metnase
showed a marked increase (3.4-fold) in chromatin
association after IR, but there was a 1.4-fold decrease
after HU (Figure 4b, right panel). This prompted us to
test whether HU induces Metnase phosphorylation.
Tagged Metnase was immunoprecipitated and then
assessed for phosphorylation using anti-pS495. After
18 h of HU exposure, there was a modest increase (1.2-
fold) in the phosphorylation of Metnase (Figure 4c).
Thus, IR stimulates phosphorylation of Metnase to a
greater extent than HU, and IR also stimulates the
association of phosphorylated Metnase with chromatin,
whereas HU decreases this association. It should be
noted that the endogenous levels of phosphorylated
Metnase protein are lower in the IR experiments
because cells were incubated at room temperature
during the mock and test radiation exposure.
We next asked whether the S495A Metnase species
co-immunoprecipitates with histone H3, the target of
the histone methylase function of Metnase (Fnu et al.,
2011). We found that the S495A Metnase interacted
signiﬁcantly less with histone H3 than the wt Metnase
(Figure 4d). We then used our previously described
HT1904 cells in chromatin immunoprecipitation (ChIP)
experiments to measure the relative concentration and
rate at which wt versus S495A Metnase associated with
a single ISce-I-induced DSB (Fnu et al., 2011). As
shown previously, wt Metnase was rapidly recruited to
the induced DSB, but the S495A mutant showed little or
no recruitment to the DSB (Figure 4e). Thus, Metnase is
phosphorylated in response to DSB damage and this
modiﬁcation is important for its recruitment to DSBs.
We then examined the role of the S495 phosphoryla-
tion on the activities of Metnase in HEK-293T cells,
which do not express Metnase by virtue of their
transformation with T antigen (Williamson et al.,
2008). Wt Metnase enhances restart of stalled forks
after replication stress from HU in these cells (De Haro
et al., 2010). Recovery of replication forks after HU
exposure can be measured by the appearance of
immunoﬂuorescent bromodeoxyuridine (BrdU) foci,
which designate regions of active incorporation of
nucleotides (Petermann et al., 2010). We found that
the cells expressing S495A Metnase had signiﬁcantly
more BrdU foci per cell than cells expressing wt
Metnase after exposure and release from HU for
15min (Figure 5a). We found that 13% of 293T cells
transduced with S495A mutant Metnase, but none
expressing wt Metnase, had >10 foci/cell (Figure 5b).
Thus, Metnase phosphorylation decreases its ability to
enhance recovery of replication forks from stress,
consistent with the known function of Chk1.
We then assessed whether the S495A mutant could
dimethylate H3K36, because it appeared that this
mutant was defective in associating with an induced
DSB. Metnase is universally expressed in human cells,
except those transformed by T antigen, for reasons that
are not clear. However, such cells serve as a useful model
to measure some Metnase functions. We found that in
HEK-293T cells, the S495A mutant had a decreased
ability to dimethylate H3K36 compared with wt
Metnase by western blot analysis (Figure 6a). ChIP
analysis corroborated this result as the S495A mutant
was unable to induce H3K36me2 at a single DSB in
HT1904 cells (Figure 6b, top panel). H3K36me2
promotes DSB repair by NHEJ, and the H3K36
methylation defect of the S495A mutant also conferred
a DSB repair defect as measured by real-time PCR using
primers ﬂanking the I-SceI DSB site (Figure 6b, bottom
panel).
The three-dimensional model of the Metnase S495 site
(Supplementary Figure 2) indicates that this region is
quite ﬂexible, suggesting that S495 phosphorylation
could affect the structure of this region, and thereby
inﬂuence DNA positioning and nucleolytic activity. To
test this, we compared the nucleolytic digestion of a
pseudo-Y structure by puriﬁed wt Metnase, which
occurs as a mixture of phosphorylated and nonpho-
sphorylated forms, and fully nonphosphorylated
S495A mutant Metnase. The S495A mutant protein
showed greater overall nucleolytic activity and produced
a greater overall variety of cleavage products compared
with wt Metnase (Figure 6c). Thus, S495 phosphoryla-
tion appears to decrease Metnase nuclease activity, but
increase cleavage speciﬁcity.
Finally, we previously reported that Metnase interacts
with Topo IIa and enhances its decatenation ability
(Williamson et al., 2008, Wray et al., 2009). Therefore,
we examined whether the S495A mutant affected
the ability of Metnase to enhance Topo IIa-mediated
Figure 3 Cellular phosphorylation of Metnase by Chk1, and
dephosphorylation by PP2A. (a) Repressing expression of Chk1
blocks Metnase S495 phosphorylation. V5-tagged Metnase was
immunoprecipitated from cells with and without repression of
Chk1 using speciﬁc small interfering RNAs (siRNAs). The
presence of phosphorylated Metnase was detected using western
blot analysis with anti-pS495. (b) Repressing expression of PP2A
enhances Metnase S495 phosphorylation. V5-tagged Metnase was
immunoprecipitated from cells with and without siRNA repression
of PP2A. The presence of phosphorylated Metnase was detected
using western blot analysis with anti-pS495.
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decatenation. We found that pure recombinant S495A
protein was still able to promote Topo IIa decatenation
(Supplementary Figure 3).
Discussion
Much of DNA replication and repair is regulated by
effector protein phosphorylation (Bartek and Lukas,
2003). Metnase is a recently described histone methylase
and nuclease with roles in both replication and repair
(Lee et al. 2005; De Haro et al., 2010). Since many of the
effectors of these functions are regulated by phosphor-
ylation, we examined whether Metnase was also
regulated by phosphorylation. We used 32P labeling of
intracellular Metnase, 2D phosphopeptide isolation and
mass spectroscopy to show that Metnase is phosphory-
lated on S495. Two lines of evidence demonstrate that
the S495 is the only Metnase phosphorylation site. First,
mutating this site completely blocked incorporation of
32P orthophosphate into Metnase after DNA damage
induction. Second, only one labeled phosphopeptide
was seen in the 2D gel after DNA damage.
S495 lies within a Chk1, Chk2 and PAK2 consensus
target sequence. Although each of these kinases
phosphorylated Metnase in vitro, Chk1 was far more
active. Inhibiting Chk1 with UCN-01 or repressing it
with small interfering RNA markedly decreased phos-
phorylation of Metnase, whereas other speciﬁc kinase
inhibitors had only minimal effect. Even a modest
knockdown of Chk1 dramatically reduced Metnase
Figure 4 Phosphorylation of Metnase S495 promotes its association with chromatin after IR but not after replication stress.
(a) Western blot analysis of chromatin-associated wt and S495A Metnase. Cells expressing Flag-tagged Metnase or the S495A mutant
were treated with 10Gy IR, and chromatin was isolated at indicated times. Ku70 and histone H3 were used as nuclear protein-loading
controls. Expression of wt and S495A Metnase, analyzed by western blot analysis in total cell extracts, is shown to the right. (b) V5-
tagged wt or S495A Metnase were immunoprecipitated with anti-V5 and phospho-S495 Metnase was detected by western blot analysis
(top panel). Middle and lower panels are V5-Metnase input and actin-loading controls, respectively. (c) Cells expressing Flag-tagged
Metnase were treated with 10Gy IR, 10mM HU or mock-treated, and phospho-S495 Metnase in chromatin-bound or unbound
fractions was detected by western blot analysis. (d) Chromatin association of wt and S495A Metnase as measured by co-
immunoprecipitation analysis. Flag-tagged wt or S495A Metnase were immunoprecipitated with anti-Flag (middle panel) and their co-
immunoprecipitation with histone H3 (top panel) was detected by western blot analysis. The lower panel shows input Metnase levels
prior to immunoprecipitation. (e) ChIP analysis of Metnase recruitment to a single DSB induced by I-SceI nuclease in HT1904 cells
transfected with empty vector or overexpressing wt or S495A Metnase (Fnu et al., 2011). ChIP was quantiﬁed by real-time PCR at
indicated times after DSB induction. * Po0.05, ** Po0.01.
Figure 5 Expression of the S495A Metnase mutant increases
replication fork recovery. (a) Confocal immunoﬂuorescence of
BrdU foci (green) in HEK-293T cells expressing either wt or S495A
Metnase species after recovery from exposure to HU. The foci
represent replication forks newly incorporating BrdU after HU has
been removed. (b) Quantifying cells expressing BrdU foci
demonstrates that cells expressing S495A Metnase have signiﬁ-
cantly more foci than with wt Metnase. More than 500 cells were
counted on at least ﬁve slides for each experimental arm.
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phosphorylation, probably due to counter-balancing
phosphatases that remain active (Leung-Pineda et al.,
2006). Consistent with this, we found that the PP2A
phosphatase dephosphorylates Metnase. Metnase may
be undergoing a continuous, dynamic cycle of phos-
phorylation–dephosphorylation by Chk1 and PP2A.
With even modest decreases in Chk1 activity, there is
substantial dephosphorylation of Metnase apparently
due to unbalanced PP2A activity. A basal level of
phosphorylated Metnase was observed, which is not
surprising because Chk1 is active even in unperturbed
cells, likely in response to endogenous replication stress
and DNA damage (Bartek and Lukas, 2003).
Metnase S495 also lies within a reasonable PKC
target. However, we do not consider PKC to be a major
kinase for Metnase for several reasons. First, Metnase is
a nuclear protein, and PKC is mainly cytoplasmic.
Second, the PKC inhibitor GF109203X had little effect
on Metnase phosphorylation. Third, although PKC has
crucial roles in apoptotic decisions upon DNA DSB
damage, it has no known role in the actual repair of
DNA DSBs (Reyland, 2009). Our data indicate that the
most important kinase responsible for Metnase phos-
phorylation is Chk1, although there is some redun-
dancy. This redundancy could be important in
activating the DNA repair activity of Metnase, as there
may be situations where DNA is damaged, and Chk1 is
not activated, but Chk2 and PAK2 are. Nonetheless,
these data place Metnase within the epistatic cascade
initiated by DNA damage, whether from exogenous or
endogenous sources. These data also implicate a role for
PP2A in replication fork recovery (either directly at
forks or indirectly through S-phase checkpoint regula-
tion) as dephosphorylated Metnase appears to be more
active in this role. This is consistent with previous
reports that PP2A is required for deactivating Chk1 by
dephosphorylation of S317, and for appropriate meta-
bolism of RPA in the recovery of stalled forks (Leung-
Pineda et al., 2006; Feng et al., 2009).
The phosphorylation of Metnase S495 inhibits its role
in replication fork recovery and stimulates its role in
DNA DSB repair. This regulation may reﬂect changes
to the Metnase nuclease activity that has greater activity
and lower speciﬁcity in the nonphosphorylated state.
Although these activity changes could reﬂect structural
changes upon phosphorylation, modeling indicates that
S495 is on the exterior surface and phosphorylation of
this residue is not expected to cause dramatic structural
changes. The altered nuclease activity of unphosphory-
lated S495A Metnase has several implications. First, the
nuclease activity of Metnase could have an important
role in replication fork recovery, because this was
increased in cells expressing S495A. Compared with wt
Metnase, the cleavage pattern of the S495A mutant
nuclease more closely resembles FEN-1, cutting close to
ﬂap junctions of fork-like structures. Second, it implies
that the greater speciﬁcity of the wt Metnase nuclease is
important for its role in DSB repair, because this
function is decreased in the S495A mutant. We have
recently reported that Metnase is important for resecting
overhangs from incompatible free DNA ends during
non-homologous end-joining repair (Beck et al., 2011).
The nuclease activity of phosphorylated Metnase may
be important in the processing of incompatible DNA
ends. Replication stress induced by HU does not
enhance association of phosphorylated Metnase with
chromatin, suggesting the possibility that the relaxed
substrate speciﬁcity of the nonphosphorylated form may
be important in processing a variety of structures at
stalled forks.
The decrease in cellular H3K36me2 seen with the
S495A Metnase species is likely due to the decreased
chromatin association of this mutant. Indeed, the
reduction in DSB repair seen with the S495A mutant
implies that H3K36me2 formation and DSB repair are
both enhanced by Metnase phosphorylation, consistent
with our previous observation that Metnase-mediated
H3K36me2 formation enhances DSB repair (Fnu et al.,
2011). In contrast, our results also suggest that Metnase
H3K36 dimethylation activity and chromatin associa-
tion are not important for the ability of Metnase to
enhance replication fork recovery after stress.
Figure 6 Metnase phosphorylation regulates its biochemical
activities. Metnase dimethylation of H3K36 and subsequent
enhancement of DSB repair requires S495 phosphorylation.
(a) Western blot analysis of H3K36me2 by wt and S495A Metnase
after DNA damage induced by HU. (b) ChIP analysis (upper
panel) of H3K36me2 over time after induction of a single DSB by
I-Sce-I with over-expression of wt or S495A Metnase. The lower
panel shows real-time PCR assessment of the re-ligation of this
induced single DSB over time. *Po0.05, **Po0.01. (c) Flap
cleavage nuclease activities of puriﬁed wt or S495A Metnase. The
upper schematic diagrams the altered S495A ﬂap nuclease activity.
The length of the arrows is proportional to the relative amount of
cleavage at each position.
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Our results suggest the following models for Metnase
function in response to replication stress and DSB
repair. With DSB damage, Chk1 is activated and it
phosphorylates Metnase. Phosphorylated Metnase is
then recruited to chromatin adjacent to the DSB, and
dimethylates H3K36 near the DSB, which stabilizes
recruited NHEJ components, such as Ku70 and NBS1,
and thereby enhances repair (Wang et al., 2001, Valerie
and Povirk, 2003, Kim et al., 2005, Lees-Miller and
Meek, 2005). As the SET domain is not likely to be
structurally altered by the S495 phosphorylation,
Metnase histone methylation activity remains intact
after phosphorylation. Thus, the decrease in H3K36me2
at the DSB region in the S495A species is likely from
decreased localization of this mutant Metnase to the
chromatin at that site. The ChIP data demonstrating the
decreased presence of Metnase at the DSB over the time
course of repair of an induced DSB supports this
hypothesis. How might Metnase phosphorylation/de-
phosphorylation regulate replication fork recovery after
stress? When Chk1 is activated during replication stress,
its canonical role is to halt replication until DNA is
repaired by phosphorylating Cdc25a, which leads to its
ubiquitinylation and degradation, and subsequent re-
plication arrest (Donzelli and Draetta 2003). We show
here that Chk1-mediated phosphorylation of Metnase is
important to maintain replication arrest during the
critical period immediately after release from replication
stress. It remains unclear how Metnase phosphorylation
helps enforce replication arrest; this function, combined
with enhanced DSB repair activity, may be an important
contributor to the essential roles of Chk1 in inhibiting
replication recovery and promoting repair. An alter-
native, but not mutually exclusive model, is that
Metnase promotes replication fork recovery after arrest
directly via its nuclease activity. In this role, Metnase
may need to be in the dephosphorylated state, as this
enhances its activity and reduces speciﬁcity toward
pseudo-Y and other structures that may arise at stalled
forks.
In summary, Metnase phosphorylation by Chk1
distinguishes its activities in repair and replication
recovery. Metnase phosphorylation enhances its locali-
zation to chromatin, and subsequent H3K36 dimethyla-
tion and DSB repair, and it helps maintain replication
arrest after release from stress, the classical role for
Chk1. These functions are signiﬁcant for the cell,
because it would be detrimental to promote replication
fork recovery before DNA damage is repaired as this
would result in signiﬁcant genomic instability or cell
death. Our data deﬁne Metnase as a novel Chk1
effector, mediating important downstream functions in
the Chk1 cascade.
Materials and methods
Cell culture, proteins and antibodies
Human HEK-293 and HEK-293T cells expressing wt and
mutant Metnase were established as previously described
(Williamson et al., 2008). Cells were grown in Dulbecco’s
Modiﬁed Eagle Medium (Hyclone, Fisher Scientiﬁc, Pitts-
burgh, PA, USA) supplemented with 10% fetal bovine serum
(Atlanta Biologicals, Lawrenceville, GA, USA) and antibiotic–
antimycotic reagent (penicillin G, 10 units/ml; streptomycin,
10 mg/ml; and amphotericin B, 0.25 mg/ml) (Invitrogen, Carls-
bad, CA, USA). Puriﬁed His-Chk1, GST-Chk2 and GST-
PAK2 kinases were obtained from Signal Chem (Richmond,
BC, Canada). The following antibodies were used: FLAG,
actin (Sigma, St Louis, MO, USA); PP2A (Millipore, Billerica,
MA, USA); H3K36me2 (Abcam, Cambridge, MA, USA);
Chk1, Chk2, PAK2 and BrdU (Cell Signaling, Danvers, MA,
USA); V5 (Invitrogen); phosphorylated S495 Metnase (pS495,
custom-made, ProSci Inc, Poway, CA, USA). Control and
Metnase-speciﬁc small interfering RNAs were used as de-
scribed previously to manipulate Metnase levels (Lee et al.,
2006; Fnu et al., 2011).
Preparation of cell lysates and immunoblot analysis
Cells (1 105) were collected, washed with PBS and lysed in a
buffer containing 25mM HEPES (pH 7.5), 0.3 M NaCl, 1.5mM
MgCl2, 0.2mM EDTA, 0.5% Triton X-100, 20mM b-glycer-
olphosphate, 1mM sodium vanadate, 1mM DTT and protease
inhibitor cocktails (Sigma). Cell lysates (50 mg) were loaded
onto a SDS–PAGE and, following gel electrophoresis, proteins
were transferred to a polyvinylidene ﬂuoride membrane
(Millipore) and immunoblotted with primary antibody fol-
lowed by peroxidase-coupled secondary antibody (Amersham,
Piscataway, NJ, USA) and an enhanced chemiluminescence
(Amersham) reaction prior to visualization on Kodak-o-mat
ﬁlm.
In vivo orthophosphate labeling
HEK-293 cells overexpressing Flag-Metnase were incubated
with 1mCi of 32P-orthophosphoric acid for 1 h. Following IR
treatment (20Gy), cells were further incubated for 1 h prior to
harvest. Cell extracts (500 mg) were mixed with agarose-
conjugated Flag-antibody beads for 1 h for immunoprecipita-
tion of Flag-Metnase. Samples were analyzed by 10% SDS–
PAGE, dried and exposed to an X-ray ﬁlm.
Phosphopeptide mapping using nano-LC/MS/MS
Coomassie blue-stained gel pieces were placed in Eppendorf
centrifuge tubes. The gel pieces were immersed in 100 ml of
50% 0.1M ammonium bicarbonate and 50% acetonitrile (by
volume) to completely cover the gel pieces. Samples were then
incubated at 37 1C for 30min. After incubation, the reagent
was withdrawn and discarded. The gel pieces were dehydrated
with 100ml of pure acetonitrile for approximately 5min, and
excess acetonitrile was decanted. The gel pieces were rehy-
drated with 100 ml of 10mM DTT and incubated at 55 1C for
45min for reduction. The reduction solution was removed and
100 ml of 55mM iodoacetamide (freshly made) was added to the
gel pieces and incubated for 30min at 37 1C for alkylation. The
gel pieces were dehydrated with 100 ml of pure acetonitrile for
approximately 5min. The excess acetonitrile was decanted and
dried under vacuum for 15min. The gel pieces were rehydrated
with a trypsin solution (Promega, Madison, WI, USA, V5280,
0.1–0.5 mg) and incubated overnight at 37 1C. Following
digestion, peptides were extracted with 0.1% triﬂuoroacetic
acid for 30min at 37 1C. Tryptic digests (10 ml) were injected
onto a 75 mm 5 cm C-18 reverse-phase column, and peptides
were eluted with a gradient from 5–45% acetonitrile developed
over 30min at a ﬂow rate of 250 nl/min using an Agilent 1100
series nano pump (Agilent, Santa Clara, CA, USA) (Firulli
et al., 2004). The column was interfaced with a LTQ ion
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trap mass spectrometer (Thermo Fisher Scientiﬁc, Pittsburgh,
PA, USA), and data were collected in the data-dependent
neutral loss MS3 mode. Neutral-loss masses were 98 (þ 1), 49
(þ 2) and 32.7 (þ 3). MS/MS and MS/MS/MS spectra were
searched against the IPI human protein database using
the SEQUEST algorithm (Sandia National Laboratory,
Albuquerque, NM, USA).
Kinase and phosphatase assays
For the in vitro kinase assays, 100 ng of each puriﬁed kinase
(Chk1, Chk2 or PAK2) was incubated with 200 ng of pure
recombinant Metnase nuclease fragment (aa 433–671) in
kinase buffer (25mM MOPS, 12.5mM a-glycerol-phosphate,
25mM MgCl2, 5mM EGTA, 2mM EDTA and 0.25mM DTT)
with 250 mM g-32P-ATP at 30 1C for 30min. Recombinant
Metnase was generated as previously described (Roman et al.,
2007). The reaction was stopped by the addition of loading dye
and proteins were separated by 4–12% gradient SDS–PAGE,
then the gel was dried and exposed to an X-ray ﬁlm.
Phosphatase reactions were carried out using immunoprecipi-
tated V5-tagged Metnase protein with 400U/ml l-phosphatase
(New England Biolabs, Ipswich, MA, USA) in the presence or
absence of phosphatase inhibitors (0.5M EDTA, 0.5M NaF
and 0.1M NaVO4). Reactions were carried out at 37 1C for
30min and proteins were separated by 4–12% gradient SDS–
PAGE. Loss of phosphorylation was shown either by exposing
the dried gel to an X-ray ﬁlm or immunoblotting with the anti-
pS495 antibody. This anti-sera had been precleared for
reaction with Metnase unphosphorylated peptide. Kinase
inhibition was carried out in vivo by incubating HEK-293
cells with various inhibitors for 1 h, immunoprecipitating the
tagged Metnase and then blotting for the presence of
phosphorylated S495 Metnase using the anti-p-ser495 anti-
body. Concentrations used were UCN-01 10mM, staurosporine
50 mM, CKII 20 mM, PD90859 10mM and GF10920 3 10mM,
all for 1 h. For phosphatase assays, okadaic acid, a PP1 and
2A inhibitor, was incubated for 1 h at 10mM.
Chk1 and PP2A knockdown
HEK-293T cells stably overexpressing wt Metnase were
transiently transfected with short hairpin RNA against Chk1
and PP2A (SABiosciences, Frederick, MD, USA) according
to the manufacturer’s instructions. Forty-eight hours after
transfection, cells were harvested and protein lysates were
prepared. Wt Metnase was immunoprecipitated and
immunoblotted with anti-pSer495 to determine the level of
phosphorylation.
Nuclease assays
Wt Metnase and the S495A mutant proteins were isolated as
previously described (Roman et al., 2007). Nuclease activity of
these proteins were carried out by incubation with g-P32
radiolabeled pseudo-Y structures and autoradiography after
separation of the cleaved products by urea denaturing gel
electrophoresis as described (Roman et al., 2007).
BrdU immunoﬂuorescence
HEK-293T cells stably expressing either wt Metnase or the
S495A mutant, or stably transfected with the empty vector
control, were seeded onto coverslips and allowed to adhere for
6 h. After this time, 10mM HU was added for 18 h. The HU
media was removed, cells were rinsed with PBS and fresh
media containing 0.03mg/ml BrdU was added (according to
Petermann et al., 2010, with BrdU substituted for IdU). BrdU
incorporation was stopped after 15min, then cells were ﬁxed
and processed for immunostaining using a BrdU-speciﬁc
antibody (Cell Signaling) according to the manufacturer’s
instructions. Images were collected using a Zeiss LSM-510
confocal microscope (Zeiss, Thornwood, NY, USA). Five-
hundred cells were counted in each condition from at least
three slides.
ChIP and real-time PCR
ChIP analysis for the presence of wt and mutant Metnase, and
H3K36me2, at the chromatin region adjacent to an induced
DSB, and DSB repair using real-time PCR was performed as
previously described (Weinmann et al., 2001, Weinmann and
Farnham, 2002, Fnu et al., 2011). Brieﬂy, HT1904 cells
containing a single allele ISce-I site in a puromycin-resistant
gene were transiently transfected with empty control vector
(pcDNA3.1) or the Metnase expression vectors (pcDNA3.1-
Metnase and pcDNA3.1-S495A). These cells were then infected
with high-titer adenovirus expressing ISce-I to induce a DSB in
the puromycin-resistant gene and cells were harvested at various
time points for ChIP analysis of H3K36me2, or wt or S495A
mutant Metnase recruitment, or DSB repair. Each experiment
was performed twice in triplicate. S.e.m. is calculated and
shown, as well as Student’s t-test for signiﬁcance. All ChIP
experimental values were obtained by real-time PCR normal-
ized to the input DNA using ampliﬁcation of glyceraldehyde-3-
phosphate dehydrogenase.
Assessment of chromatin-bound Metnase species
Immunoblot analysis of chromatin-bound Metnase was
carried out as previously described (Lee et al., 2006). HEK-
293 cells were harvested for 1 h following IR treatment, and
treated with cell lysis buffer I (25mM Hepes, pH 7.5, 0.3M
NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.5% Triton X-100,
0.5mM DTT and 1mM PMSF) and incubated for 90min on
ice. After centrifugation at 14 000 g for 30min, pellets were
extensively washed four times with cell-lysis buffer I,
resuspended in SDS–PAGE loading buffer, and analyzed by
a 10% SDS–PAGE. Gels were transferred to polyvinylidene
ﬂuoride membrane, probed with anti-FLAG (for Metnase),
-Ku70 or -histone H3 antibody (monoclonal mouse IgG;
Oncogene Sciences, Cambridge, MA, USA) followed by HRP-
conjugated secondary antibody. Proteins were visualized by
using the ECL system (Amersham).
Modeling of Metnase
The S495 phosphorylation site was modeled in a three-
dimensional structure of Metnase generated using PyMOL v.
0.99 X-ray crystallographic structures of Metnase (3F2K,
3K9J and 3K9K) and the MOS-1 Mariner transposase (2F7T)
(Arnold et al., 2009; Goodwin et al., 2010). The Metnase
structure from the SWISS-MODEL Repository was super-
imposed in DeepView/SwissPDBViewer v.4.0.1 (http://
spdbv.vital-it.ch/) using the alpha carbons.
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